https://www.selleckchem.com/products/mk-4827.html
This paper describes the detailed statistical analysis plan for the evaluation of primary and secondary endpoints of the ProPAC-COVID study. Enrolment of patients to the ProPAC-COVID study is still ongoing. The purpose of this paper is to provide primary publication of study results to prevent selective reporting of outcomes, data-driven analysis, and to increase transparency. ClinicalTrials.gov NCT04322396 . Registered on 26 March 2020. ClinicalTrials.gov NCT04322396 . Registered on 26 March 2020. The use of warfarin in patients with n
Like
Comment
Share
